Inactive Instrument

Fresenius Kabi Oncology Ltd Stock

Equities

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

2016	AstraZeneca sells rights to anaesthetics for up to $770 million	RE
2015	Fresenius SE KGaA : Kabi sells German oncology compounding business	RE

AstraZeneca sells rights to anaesthetics for up to $770 million	16-06-09	RE
Fresenius SE KGaA : Kabi sells German oncology compounding business	15-02-16	RE
Fresenius Kabi Oncology Ltd : India revokes GSK cancer drug patent in latest Big Pharma blow	13-08-02	RE
Fresenius Kabi Oncology Ltd : India board revokes GSK patent on breast cancer drug Tykerb	13-08-02	RE

Managers	Title	Age	Since
Arvind Kumar Sharma CEO	Chief Executive Officer	-	18-06-30
Rahul Sharma DFI	Director of Finance/CFO	-	-
Maria Gobbi CHM	Chairman	-	14-11-12

Members of the board	Title	Age	Since
Michael Schönhofen BRD	Director/Board Member	63	08-08-10
Nikhil Kulshreshtha BRD	Director/Board Member	-	07-07-20
Maria Gobbi CHM	Chairman	-	14-11-12

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.37%	103B
REGENERON PHARMACEUTICALS, INC.	+1.87%	95.28B
ARGENX SE	+1.46%	22.15B
BIONTECH SE	-15.61%	21.02B
GENMAB A/S	-8.58%	18.15B
WUXI APPTEC CO., LTD.	-38.74%	16.73B
BEIGENE, LTD.	-12.91%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+5.29%	13.68B
SAREPTA THERAPEUTICS, INC.	+35.51%	12.17B